Edwards Lifesciences Corp
(LTS:0REN)
CHF
77.55964
0 (0%)
Market Cap: 39.49 Bil
Enterprise Value: 36.14 Bil
PE Ratio: 10.59
PB Ratio: 4.54
GF Score: 82/100 Edwards Lifesciences Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021 / 03:00PM GMT
Release Date Price:
CHF77.56
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
Thank you for joining us for the third day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley. It's my pleasure to have Edwards' CFO, Scott Ullem, with us today.
And really quickly before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. (Operator Instructions)
And with that, Scott, thank you for joining us today.
Scott B. Ullem
Edwards Lifesciences Corporation - Corporate VP & CFO
It's my pleasure. Good morning. A pleasure to be here.
Questions & Answers
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
And I wanted to start off with the focus topic among everyone these
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot